Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06623461 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

Study acronym: Canbiome2
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 14 to 15
    • Eligibility criteria expanded, about 37 words
    • Publications: details revised at 1 of 1 entry
  2. Site contacts updated at 1 of 14 sitesv20
  3. Re-verified, no change to tracked fieldsv19
  4. Site details revised at 1 of 14 sitesv18
  5. Eligibility criteria expanded, about 28 wordsv17
Show 15 earlier versionsHide 15 earlier versions
  1. Study sites: 13 to 14v16
  2. Study sites: 11 to 13v15
  3. Study sites: 8 to 11v14
  4. Study sites: 5 to 8v13
  5. Study sites: 4 to 5v12
  6. Study sites: 3 to 4v11
  7. Study completion date: Jun 30, 2029 to Dec 31, 2029v10
  8. Study sites: 1 to 3v9
  9. Start date: Mar 26, 2025 to Apr 7, 2025v8
  10. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 30, 2025 to Mar 26, 2025
    • Site details revised
    v7
  11. Start date: Feb 28, 2025 to Apr 30, 2025v6
  12. Study sites: 0 to 1v5
  13. Collaborators revised (3)v4
  14. Re-verified, no change to tracked fieldsv3
  15. Start date: Dec 31, 2024 to Feb 28, 2025v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being done to answer the following question: Can the chance of melanoma growing or spreading be lowered by receiving a treatment called LND101 for Fecal Microbiota Transplant (FMT) in addition to the usual immunotherapy treatment called Immune Checkpoint Blockade (ICB)? FMT treatment changes the bacteria in your gut called the microbiome.
Trial Details
NCT Number NCT06623461
Lead Sponsor Canadian Cancer Trials Group
Collaborators: Canadian Institutes of Health Research (CIHR), Canadian Cancer Society (CCS), Weston Family Foundation
Conditions
(from sponsor)		 Melanoma
Related terms Melanoma
Enrollment 128 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov